These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 38140004)
1. Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT). Järvinen J; Pulkkinen H; Rautio J; Timonen JM Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140004 [TBL] [Abstract][Full Text] [Related]
2. Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy. Watanabe T; Sanada Y; Hattori Y; Suzuki M J Radiat Res; 2023 Jan; 64(1):91-98. PubMed ID: 36371738 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma. Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947 [TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of boronated unnatural amino acids as new boron carriers. Kabalka GW; Yao ML; Marepally SR; Chandra S Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346 [TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS). Chandra S; Ahmad T; Barth RF; Kabalka GW J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609 [TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Barth RF; Soloway AH; Brugger RM Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358 [TBL] [Abstract][Full Text] [Related]
7. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Wongthai P; Hagiwara K; Miyoshi Y; Wiriyasermkul P; Wei L; Ohgaki R; Kato I; Hamase K; Nagamori S; Kanai Y Cancer Sci; 2015 Mar; 106(3):279-86. PubMed ID: 25580517 [TBL] [Abstract][Full Text] [Related]
8. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation. Barth RF; Yang W; Coderre JA J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703 [TBL] [Abstract][Full Text] [Related]
9. Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry. Flieger S; Takagaki M; Kondo N; Lutz MR; Gupta Y; Ueda H; Sakurai Y; Moran G; Kempaiah P; Hosmane N; Suzuki M; Becker DP Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108137 [TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy. Fukumura M; Nonoguchi N; Kawabata S; Hiramatsu R; Futamura G; Takeuchi K; Kanemitsu T; Takata T; Tanaka H; Suzuki M; Sampetrean O; Ikeda N; Kuroiwa T; Saya H; Nakano I; Wanibuchi M Sci Rep; 2023 Jun; 13(1):10173. PubMed ID: 37349515 [TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580 [TBL] [Abstract][Full Text] [Related]
13. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Barth RF; Zhang Z; Liu T Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575 [TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy of cancer: current status and future prospects. Barth RF; Coderre JA; Vicente MG; Blue TE Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333 [TBL] [Abstract][Full Text] [Related]
15. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice. Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057 [No Abstract] [Full Text] [Related]
16. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Coghi P; Li J; Hosmane NS; Zhu Y Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375 [TBL] [Abstract][Full Text] [Related]
17. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT). Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237 [TBL] [Abstract][Full Text] [Related]
18. Fructose-functionalized polymers to enhance therapeutic potential of p-boronophenylalanine for neutron capture therapy. Nomoto T; Yao Y; Inoue Y; Suzuki M; Kanamori K; Takemoto H; Matsui M; Tomoda K; Nishiyama N J Control Release; 2021 Apr; 332():184-193. PubMed ID: 33636247 [TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery for boron neutron capture therapy. Mehta SC; Lu DR Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724 [TBL] [Abstract][Full Text] [Related]
20. The synthesis and use of boronated amino acids for boron neutron capture therapy. Kabalka GW; Yao ML Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]